<!doctype html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <title>ICU Pneumonia: Does Inhaling Antibiotics Work?</title>
    <style>
      @import url("https://fonts.googleapis.com/css2?family=Patrick+Hand&display=swap");

      body {
        margin: 0;
        padding: 40px;
        background: #fff9e6;
        font-family: "Patrick Hand", cursive;
        color: #333;
      }

      .infografia {
        max-width: 800px;
        margin: auto;
        background: #fffdf5;
        border: 2px dashed #d4a017;
        border-radius: 12px;
        padding: 30px;
        box-shadow: 0 0 12px rgba(0, 0, 0, 0.1);
      }

      h1 {
        font-size: 2.2em;
        color: #b8860b;
        text-align: center;
        margin-bottom: 20px;
      }

      h2 {
        font-size: 1.8em;
        color: #b8860b;
        margin-top: 30px;
      }

      p,
      li {
        font-size: 1.25em;
        line-height: 1.5;
        text-align: justify;
      }

      .resumen {
        background: #ffe680;
        padding: 15px;
        border-left: 5px solid #d4a017;
        margin-bottom: 30px;
      }

      /* --- ESTILOS PARA LA IMAGEN (ACTUALIZADOS) --- */
      .imagen-espacial {
        max-width: 800px; /* Ancho completo del contenedor */
        height: 280px; /* Altura fija para recortar */
        margin: 25px auto;
        overflow: hidden; /* Oculta el sobrante */
        border-radius: 10px;
        border: 3px solid #d4a017; /* Borde a juego con el tema */
        position: relative;
      }

      .imagen-espacial img {
        width: 100%;
        height: auto;
        position: absolute;
        left: 0;
        top: 50%;
        transform: translateY(-50%); /* Centra la imagen verticalmente */
      }
      /* --- FIN DE ESTILOS PARA LA IMAGEN --- */

      .highlight {
        background: #ffe680;
        padding: 2px 6px;
        border-radius: 4px;
      }

      .badge {
        display: inline-block;
        background: #ffd966;
        color: #5c3d00;
        padding: 4px 10px;
        border-radius: 20px;
        font-weight: bold;
        margin: 4px 2px;
      }

      footer {
        text-align: center;
        font-size: 0.9em;
        color: #666;
        margin-top: 30px;
      }
    </style>
    <base target="_blank" />
  </head>
  <body>
    <div class="infografia">
      <h1>
        ðŸ©º Superbug Pneumonia in the ICU: Is Inhaling the Antibiotic Better?
      </h1>

      <div class="resumen">
        <p>
          <strong>In short:</strong> Colistin is a last-resort antibiotic for
          severe pneumonia, but its intravenous (IV) version is toxic to the
          kidneys. This study investigated whether delivering colistin
          <span class="highlight">directly to the lungs (nebulized)</span>
          instead of IV is an effective and safer strategy for ICU patients.
        </p>
      </div>

      <!-- Imagen Centrada -->
      <div class="imagen-espacial">
        <img
          src="/images/i/i.jpg"
          alt="IlustraciÃ³n de antibiÃ³ticos nebulizados para tratar la neumonÃ­a"
        />
      </div>

      <h2>ðŸŽ¯ The Problem: Hospital-Acquired Pneumonia and Kidneys at Risk</h2>
      <p>
        In the Intensive Care Unit (ICU), pneumonia caused by
        <span class="badge">superbugs</span> resistant to common antibiotics
        (CR-GNB) is a major threat. Treatment with IV colistin is an option, but
        the risk of
        <span class="highlight">severe kidney damage (nephrotoxicity)</span> is
        very high, especially in patients who are already critically ill.
      </p>

      <h2>ðŸ”¬ The Question and the Study</h2>
      <p>
        Could we avoid IV colistin and instead use only the nebulized (inhaled)
        version along with other, less toxic IV antibiotics? To answer this,
        researchers reviewed the records of 557 ICU patients with this type of
        pneumonia. They compared those who received
        <span class="badge">nebulized colistin</span> as a substitute with those
        who did not.
      </p>

      <h2>ðŸ“Š Key Findings: Nebulization Works!</h2>
      <ul>
        <li>
          Patients who received nebulized colistin had a
          <span class="highlight"
            >significantly lower rate of clinical failure</span
          >. In other words, their treatment was more successful at 7, 14, and
          28 days.
        </li>
        <li>
          Even after adjusting for patient severity, the use of nebulized
          colistin was an independent factor associated with a
          <span class="highlight">better treatment outcome</span>.
        </li>
        <li>
          <strong>Safety:</strong> There was no difference in the occurrence of
          new kidney problems requiring dialysis, suggesting that the nebulized
          strategy is <span class="badge">much safer for the kidneys</span>.
        </li>
        <li>
          Interestingly, no significant differences in outcomes were found
          between administering a high or low dose of nebulized colistin.
        </li>
      </ul>

      <h2>âœ… Conclusion: A Valid Substitutive Strategy</h2>
      <p>
        For critically ill patients in the ICU with superbug pneumonia, using
        nebulized colistin instead of the intravenous version (in combination
        with other antibiotics) is a strategy associated with
        <span class="highlight">better clinical outcomes and is safer</span>.
      </p>
      <p>
        This approach allows the infection to be targeted directly in the lungs
        without exposing the entire body, and especially the kidneys, to the
        toxic effects of IV colistin.
      </p>

      <footer>
        Source: Feng et al., 2023. <em>Annals of Intensive Care</em>. DOI:
        <a href="https://doi.org/10.1186/s13613-022-01088-4" target="_blank"
          >10.1186/s13613-022-01088-4</a
        >
      </footer>
    </div>
  </body>
</html>
